Default company panoramic image

Wibi+Works, LLC

Improved stem cell therapies to treat pain

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded May 2010
  • Employees 2
  • Website

Company Summary

Wibi+Works, LLC. located in the Janssen Labs incubator space, is a privately held, emerging biotech company focused on developing and commercializing new anti-inflammatory stem cell therapies for pain. Pain is the most common reason patients seek medical attention. Most drugs can not effectively treat pain and many come with adverse side effects. Our improved anti-inflammatory cell therapy will alleviate pain with little unwanted consequences.


  • Default avatar
    Ruth S Waterman

    is an Assistant Professor of the Department of Anesthesiology at UCSD. Along with her clinical practice she has experience in both bench research and in conducting clinical trials. Her pioneering studies with the use of anti-inflammatory stem cells for the treatment of pain in diabetics were recently published and featured in various press releases. She has been awarded the Foundation for Anesthesiology Education and Research Fellowship Grant.

  • Default avatar
    Aline M. Betancourt
    Founder and CSO

    is a recognized expert in the field of stem cells, cancer, and stem cell-based therapies. She has greatly contributed to the understanding of many aspects of human bone marrow-derived mesenchymal stem cells (MSCs) over the last decade. Her patent-pending technology has been successfully tested in several pre-clinical models of human disease and is exclusively licensed by Wibi+Works, LLC.


  • Default avatar
    Mark E. Andrews